PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$25.01

Market cap

$142.54B

P/E Ratio

19.09

Dividend/share

$1.72

EPS

$1.31

Enterprise value

$205.3B

?
Relative Growth: Rel. Growth: 26
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 62

At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer ...

Highlights
Pfizer's equity has increased by 4.2% QoQ
Pfizer's gross profit has increased by 3.1% YoY
The quick ratio has grown by 9% from the previous quarter but it has contracted by 6% YoY
The price to earnings (P/E) is 16% higher than the last 4 quarters average of 16.4 and 2.1% higher than the 5-year quarterly average of 18.7
Pfizer's EPS has decreased by 6% YoY and by 4.4% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.pfizer.com
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE

PFE stock price

How has the Pfizer stock price performed over time
Intraday
0.4%
1 week
1.92%
1 month
3.86%
1 year
7.39%
YTD
0.44%
QTD
3.86%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$63.32B
Gross profit
$46.55B
Operating income
$7.91B
Net income
$7.49B
Gross margin
73.5%
Net margin
11.8%
The operating income has grown by 7% YoY and by 5% from the previous quarter
PFE's net margin is down by 6% YoY and by 4.8% from the previous quarter
The company's operating margin rose by 6% YoY and by 4.2% QoQ
Pfizer's net income has decreased by 5% YoY and by 3.6% QoQ

Price vs fundamentals

How does PFE's price correlate with its fundamentals

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
19.09
P/B
1.58
P/S
2.25
EV/EBIT
26.07
EV/EBITDA
14.2
EV/Sales
3.24
The price to earnings (P/E) is 16% higher than the last 4 quarters average of 16.4 and 2.1% higher than the 5-year quarterly average of 18.7
Pfizer's EPS has decreased by 6% YoY and by 4.4% from the previous quarter
PFE's P/B is 31% below its 5-year quarterly average of 2.3
Pfizer's equity has increased by 4.2% QoQ
PFE's P/S is 17% below its 5-year quarterly average of 2.7 but 2.3% above its last 4 quarters average of 2.2

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital rose by 8% YoY and by 4.4% QoQ
Pfizer's ROS has increased by 5% YoY and by 3.3% from the previous quarter
The ROE fell by 4.5% YoY and by 3.4% QoQ
Pfizer's ROA has decreased by 2.7% from the previous quarter and by 2.7% YoY

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.72
Dividend yield
6.88%
Payout ratio
131.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Pfizer financials performed over time
PFE's total assets is 77% greater than its total liabilities
The quick ratio has grown by 9% from the previous quarter but it has contracted by 6% YoY
The current ratio has grown by 8% from the previous quarter
PFE's debt is 28% less than its equity
PFE's debt is up by 3.8% YoY
Pfizer's equity has increased by 4.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.